Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. (PRAX) Revenue
Annual & quarterly revenue history · segment & region breakdown
PRAX · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsPraxis Precision Medicines, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 100.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2018 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | -$0.01B | -100.00% |
| 2024-12-31 | $0.01B | +$0.01B | +249.53% |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | +$0.00B | — |
| 2018-12-31 | $0.00B | — | — |
Compare revenue vs peers
BiotechnologyCompare PRAX revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Praxis Precision Medicines, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Praxis Precision Medicines, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Praxis Precision Medicines, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PRAX revenue · 4 questionsPRAX's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 100.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Praxis Precision Medicines, Inc. SEC filings · GAAP · Praxis Precision Medicines, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026